Navigation Links
Hospira Advances Patient Safety With New GemStar(R) SP Infusion System
Date:2/25/2009

- Safety Protocol Integration Enhances Market-Leading GemStar Medication Management Pump -

LAKE FOREST, Ill., Feb. 25 /PRNewswire-FirstCall/ --Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced the introduction of the GemStar(R) SP infusion system with GemStar(TM) Infusion Suite software, an advanced version of the market-leading, multi-application, GemStar pump. The GemStar SP infusion system is designed to help caregivers better incorporate patient safety best practices right at the patient's bedside.

GemStar SP incorporates GemStar Infusion Suite software, a stand-alone personal computer (PC)-based application designed to enhance safe and efficient medication administration. In an effort to help clinicians combat the 1.5 million medication errors that occur annually(1), GemStar SP allows healthcare facilities to tailor the pump to meet specific clinical objectives.

The compact and portable pump has configurable settings to help streamline the programming process for clinicians and provide flexible drug protocols with hard limits to help prevent medication errors. GemStar also offers several security features including four keypad lockouts, integral set-based free flow protection and mandatory confirmation screens, to help minimize the risk of medication delivery errors.

"The new GemStar Infusion Suite software allows clinicians to quickly recall a pre-configured drug safety suite for safer, and more efficient drug delivery," said Steven Pregulman, M.D., global medical director, Device Development, Hospira. "The advancements made with GemStar SP reinforce Hospira's position as a leading provider of safety medication administration products for all infusion needs."

With the addition of GemStar SP to the produ
'/>"/>

SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Biogenerics Will Save Billions, Says Hospira CEO
2. Hospiras Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval
3. Hospira Expands Board of Directors
4. Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira
5. Hospira Hosts Conference Call for Third-Quarter 2008 Earnings
6. StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists
7. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
8. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
9. Verenium Advances Its Development Work With Cargill on a New Food-Related Product
10. EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference
11. Response Genetics CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCal...ay it has completed enrollment in the Phase II cli...008/2009 recommended strains) VLP vaccine candidat...r adults). This randomized, double-blind, active-...lity and immunogenicity of two different doses (15...
(Date:11/30/2009)... , SHANGHAI, Nov. 30 /PRNewswire-Asia/ ...ceutical, biotechnology, and medical-device resear...ions in China and the United States,announced tha...Fast 50 China,2009 list for the fifth consecutive ...ompanies in China,s technology, media, and telecom...
(Date:11/27/2009)... , DURHAM, N.C., Nov. 27 C...l initiate water-soluble carbon nanotube-based can...water-soluble carbon nanotubes, which have functio...n with cancer drugs, was developed in partnership ...jugated carbon nanotubes serves as a drug delivery...
(Date:11/25/2009)... , BOSTON, Nov. 25 Biotech...virus, genomic data from the 1918 pandemic through...rent H1N1 pandemic, today issued its latest bioche...at the lethality of the H1N1 ("Swine Flu") virus h...the virus,s current outbreak in the spring of 2009...
Breaking Biology Technology:NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5
...ship Completes CTI,s Transformation to Commercial ... SEATTLE, April 24 Cell Therapeutics, Inc.,(Nasd...ilips, most recently,Vice President and General Ma... President of CTI with direct responsibilities for...ive August 1, 2008. Philips, responsibilities,will...
... April 23 Anadys Pharmaceuticals,Inc. (Nasdaq: A...arter 2008,financial results on Wednesday, April 3... Anadys will hold a conference call and webcast to...and highlights and to provide an update on,its dev...5:00 p.m. Eastern,Daylight Time. A live webcast of...
...iz., April 23 ImaRx Therapeutics,Inc. (Nasdaq: I...agreement,with Abbott Laboratories pursuant to whi...million non-recourse promissory note with Abbott i...ase. As a result, full title to,the urokinase asse...product, all regulatory and clinical documentation...
Other Biology Technology:Veteran Drug Industry Executive to Become President of CTI 2Veteran Drug Industry Executive to Become President of CTI 3Veteran Drug Industry Executive to Become President of CTI 4Anadys Pharmaceuticals to Report First Quarter 2008 Financial Results 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 3
(Date:11/26/2009)... Whitehead researchers have developed a new type ...ific genes and proteins used by pathogens, accordi...cell cultures genes are present in two copies: one.... Gene inactivation by mutation is therefore ineff...econd copy usually remains active and takes over. ...
(Date:11/26/2009)...ococcus Aureus ) and other drug-resistant bacteria... prototype devices have been developed to offer sa...ls. , Two prototype devices have been developed:....g. hands and feet) in hospitals and public spaces...her to shoot bacteria-killing agents into infested...
(Date:11/25/2009)...tomach, may be used to boost resistance to, or slo...hool of Medicine researchers report in a study pub...cience . , Parkinson,s disease is caused by a de...idbrain known as the substantia nigra, which is re...tion of dopamine in late-stage Parkinson,s causes ...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Hormone ghrelin can boost resistance to Parkinson's disease 2As Greenland melts 10423 1As Greenland melts 10423 2MU research team establishes family tree for cattle other ruminants 10421 1MU research team establishes family tree for cattle other ruminants 10421 2EPA fellow studies effect of mercury in toads 10419 1EPA fellow studies effect of mercury in toads 10419 2
...hagic fever have been reported in Angola. Of these...irst 6 cases, bringing the number of affected prov...ern part of the country. , Mobile surveillance tea...rday when vehicles were attacked and damaged by lo...no surveillance teams were operational today in th...
...ns researchers report that two proteins best known...her to turn the liver into a sugar-producing facto...tion of sugar is a damaging problem in people with...rget for future drugs to fight the disease, the re...liver,s production of sugar is a back-up plan that...
...ns researchers report that two proteins best known...her to turn the liver into a sugar-producing facto...tion of sugar is a damaging problem in people with...rget for future drugs to fight the disease, the re...liver,s production of sugar is a back-up plan that...
Other Biology News:WHO suspends Marburg work, appeals for new funds 2Computational verification of protein-protein interactions by orthologous co-expression 2Computational verification of protein-protein interactions by orthologous co-expression 3Future diabetes drugs may target new protein interaction 2Future diabetes drugs may target new protein interaction 3
Custom Human Cytokine Antibody Array, Choose from hundreds of proteins. from Raybiotech, Inc.
Goat Anti-Mouse Ig + IgM Antibody, FITC Conjugated from Cayman Chemical
CopyControl Induction Solution from EPICENTRE Biotechnologies
RNase III from Ambion
Biology Products: